Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vivani Medical, Inc.
Vivani Medical Announces Private Placement Equity Financing
November 16, 2026
Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects
November 12, 2026
Vivani Medical Reports Third Quarter 2026 Financial Results and Provides Business Update
November 12, 2026
Vivani Medical Announces Participation in Upcoming Investor Conferences
October 12, 2026
Vivani Medical Announces Participation in Upcoming Investor Conferences
September 3, 2026
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
August 6, 2026
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
May 28, 2026